Zhejiang Cancer Hospital — Hangzhou, Zhejiang

Public research footprint of Zhejiang Cancer Hospital, compiled from the ClinicalTrials.gov public registry.

933

Registered studies

468

Active

273

Recruiting now

235

Completed

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer · Locally Advanced (Unresectable) or Metastatic Solid Tumors · Breast Neoplasms · Non-Small Cell Lung Cancer (NSCLC)

Recently updated registry entries

NCT05067283 — A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001) (Recruiting)
NCT05388669 — A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab… (Active Not Recruiting)
NCT06662786 — A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Zhejiang Cancer Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.